AI assistant
NextCure, Inc. — Director's Dealing 2019
May 14, 2019
35069_dirs_2019-05-13_f3548f37-a8da-4343-80da-935ec3a9edb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-13
Reporting Person: Khuong Chau Quang (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-13 | Common Stock | C | 445866 | — | Acquired | 445866 | Indirect |
| 2019-05-13 | Common Stock | C | 743110 | — | Acquired | 1188976 | Indirect |
| 2019-05-13 | Common Stock | C | 729599 | — | Acquired | 1918575 | Indirect |
| 2019-05-13 | Common Stock | C | 442438 | — | Acquired | 2361013 | Indirect |
| 2019-05-13 | Common Stock | P | 350000 | $15.00 | Acquired | 2711013 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-13 | Series A-1 Preferred Stock | $ | C | 3582000 | Disposed | Common Stock (445866) | Indirect | |
| 2019-05-13 | Series A-2 Preferred Stock | $ | C | 5970000 | Disposed | Common Stock (743110) | Indirect | |
| 2019-05-13 | Series A-3 Preferred Stock | $ | C | 5861455 | Disposed | Common Stock (729599) | Indirect | |
| 2019-05-13 | Series B-1 Preferred Stock | $ | C | 3554466 | Disposed | Common Stock (442438) | Indirect |
Footnotes
F1: The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
F2: OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. The Reporting Person is an employee of OrbiMed Advisors. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein. Each of GP VI, OrbiMed Advisors and the Reporting Person disclaims beneficial ownership of the shares held by OPI VI, except to the extent of its or his pecuniary interest therein, if any.